Lundbeck
HLUN-B.CO
#2799
Rank
โ‚น557.19 B
Marketcap
โ‚น561.61
Share price
0.46%
Change (1 day)
19.09%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): โ‚น52.79

According to Lundbeck's latest financial reports the company's current EPS (TTM) is โ‚น55.72. an increase over its 2024 EPS that were of โ‚น40.23.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025โ‚น46.0714.5%
2024โ‚น40.2329.29%
2023โ‚น31.1223.09%
2022โ‚น25.2837.26%
2021โ‚น18.42-84.61%
2020โ‚น119.68-24.61%
2019โ‚น158.74-42.06%
2018โ‚น273.9840.7%
2017โ‚น194.73146.26%
2016โ‚น79.07-120.48%
2015-โ‚น386.023231.32%
2014-โ‚น11.59-115.78%
2013โ‚น73.42-23.36%
2012โ‚น95.80-48.01%
2011โ‚น184.29-9.68%
2010โ‚น204.0513.72%
2009โ‚น179.4224.32%
2008โ‚น144.33-6.05%
2007โ‚น153.6281.77%
2006โ‚น84.51-16.76%
2005โ‚น101.53-17.58%
2004โ‚น123.19